Company overview

LEO Pharma International (LPI) Athens is the managerial centre supporting all LEO activities in the Middle East.


We were established in Athens, Greece, in 1976 and have over the years achieved a leading position with products like Fucidin®, Fucithalmic®, One-Alpha®, Daivonex®, Daivobet® and Innohep® in most of the countries serviced.


Being a part of LEO Pharma, Denmark, we provide the highest possible standards of general management, sales and marketing, regulatory and medical support. This support goes to our own LEO sales organisations in the region as well as to our importers/distributors, all committed to serve the medical profession the best way possible.


Since the LEO Foundation owns the entire LEO Group, we have no external shareholders. This means that all money earned from sales of LEO products go back into research and development of new, unique treatment methods. LEO is thus committed to the long-term research goals, which are necessary to continue the development of LEO as a successful, efficient, responsible, professional research-based company.


Out of the approximate 4,500 LEO employees’ world-wide, there are 250 working in the LPI Athens region distributed as follow:


The support office in Athens, Greece, holds 18 employees
The local countries with LEO sales organisations hold another 150 employees

 

Countries served by LEO Pharmaceutical Products Sarath Ltd. are:

  • Bahrain
  • Egypt
  • Jordan
  • Iran
  • Iraq
  • Kuwait
  • Lebanon
  • Libya
  • Oman
  • Palestine
  • Qatar
  • Saudi Arabia
  • Sudan
  • Syria
  • Turkey
  • U.A.E.
  • Yemen


Staff Photos

 


More information about LEO Pharma can be found on LEO Pharma's corporate website:
http://www.leo-pharma.com